Jasper Therapeutics, Inc. (JSPR): Nasdaq/NYSE listing notice — Jasper Therapeutics receives Nasdaq bid price deficiency notice; 180 days to cure

Jasper Therapeutics, Inc.

On June 3, 2026, Nasdaq notified Jasper that its common stock bid price closed below $1.00 for 30 consecutive business days.
Company has until November 30, 2026 to regain compliance by achieving $1.00+ close for at least 10 consecutive days.
If not cured by Nov 30, Jasper may qualify for an additional 180-day period subject to other listing standards and potential reverse stock split.
Failure to cure could result in delisting of common stock and warrants from Nasdaq Capital Market.
Jasper intends to monitor bid price and consider options including a reverse stock split.

item 3.01

Featured in Daily 8-K Digest

Selected #4 for 2026-06-09. Read digest

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Jasper Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

June 3, 2026, Jasper Therapeutics, Inc. (the “Company”) received written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last thirty consecutive business days, the bid price for the Company’s voting common stock had closed below the minimum $1.00 per share requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (“Rule 5550(a)(2)”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar days, or until November 30, 2026, to regain compliance. The N

View on SEC.gov

95 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Jasper Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001213900-26-066782

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.